Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

COOPER TEARS - Health Canada Drug Approval Details

Approvals/Health Canada/COOPER TEARS

Authorized

STANDARD

COOPER TEARS

Coopervision Inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 1b9d1debb578576c
Company: Coopervision Inc.
Type: Standard

Approval Details

Approval Id: 1b9d1debb578576c
Drug Approval Canada Name: COOPER TEARS
Product Name: COOPER TEARS
Status: Cancelled Post Market
Status Date: 1998-03-12
Original Market Date: 1996-08-14
Din: 02174898
Drug Class: Human
Dosage Form: Drops
Route Of Administration: Ophthalmic
Schedule: OTC
Ahfs: 52:92.00
Atc Original: S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Atc Name: s 01 xa 20
Aig Number: 0107589002
Company Name: Coopervision Inc.
Company Address: 100 Mcpherson Street, Markham, Ontario, Canada, L3R 3V6
Company Detail Path: /organization/coopervision-inc-united-states

Company Information

Pharmaceutical Company Name: Coopervision Inc.
Country Name: United States
Province Name: California
City Name: pleasanton,california,country_us
Address: 5870 Stoneridge Dr Ste 1

Active Ingredients

POLYVINYL ALCOHOL

1 %

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1b9d1debb578576c

Type

Standard

Back to Health Canada Approvals